Implant Sciences (IMSC) reached a plateau of $1.00 yesterday, a significant achievement for a company that been struggling to find consistent success in the last few months. After a slew of globalization announcements, the company reached $1.10 on May 10th, 2012, before falling back down to $0.93 on May 17th, 2012.
The recent surge of 11% suggests that the company is finally being rewarded for its increased effort to extend itself to a global market.
Implant Sciences is a company that develops, manufactures and sells ‘smart’ sensors. The sophisticated sensors are used for security, safety and defense systems. Essentially, the products created by the company are a way to outsource ‘human cognition’; put another way, it is the use of technology to make human actions easier. As technology continues to grow at an exponential rate, it should come as no surprise that a company such as Implant Sciences is finding success in the market.
May 22nd, 2012: the company announced that it had sold ten units of its Quantum Sniffer(TM), a handheld explosive tracer, to a customer in Romania. This is first sale to a Romanian and was effectuated by the company’s Romanian-based distributor, Business Plus.
May 23rd, 2012: Implant Sciences rose to $0.95 from $0.89.
May 24th, 2012: it was announced that the company had shipped its Quantum Sniffer to customers in Nigeria, Uganda, as well as the Republic of Mali. If anything, these shipments increase the reach Implant Sciences have in African nations.
May 29th, 2012: the company once again reached a high of $0.95.
There is a definite trend here between the announcements of globalization and the increase of the company’s stock. It shouldn’t come as any surprise. Stock market investors have long been basing where they put their cash on the odds of whether or not a company can become not just a local success, but an international one, as well. More sales on an international scale increase the overall ‘safety net’ of a company’s success; in other words, it gives investors greater peace of mind.
The most recent surge in the market comes after an announcement made on June 20th, 2012. The company announced that Mo McGowan, a veteran of the United States Transportation and Security Administration (TSA) , had been retained on as an adviser. This was done through a contract with the international security and intelligence consulting firm.
This addition comes as no surprise. McGowan has spent over seven years at the TSA and is recognized by some as one of the founders of the organization. Analysts are looking at what McGowan can bring to a company like Implant Sciences. His experience suggests that he knows how to spend a budget and reach different marketplaces across the world.
Moving forward, if Implant Science can properly utilize a veteran like McGowan, and if they can continue to attract sales in foreign countries, then further rise may be imminent.
For consideration of being featured on WallstreetPR, contact: Editor@Wallstreetpr.com
